{"id":"https://openalex.org/W2138644435","doi":"https://doi.org/10.1016/s0009-9236(97)90176-4","title":"Triazolam is ineffective in patients taking rifampin","display_name":"Triazolam is ineffective in patients taking rifampin","alternate_titles":[],"publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W2138644435","doi":"https://doi.org/10.1016/s0009-9236(97)90176-4","mag":"2138644435","pmid":"https://pubmed.ncbi.nlm.nih.gov/9024169"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(97)90176-4","doi":"https://doi.org/10.1016/s0009-9236(97)90176-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(97)90176-4","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2138644435"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109274630","display_name":"Kirsti Villikka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Kirsti Villikka","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Finland","Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109328662","display_name":"Kari T. Kivist\u00f6","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Kari T. Kivist\u00f6","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017096947","display_name":"Janne T. Backman","orcid":"https://orcid.org/0000-0002-9577-2788","observed_orcids":["https://orcid.org/0000-0002-9577-2788"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Janne T. Backman","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091721438","display_name":"Klaus Tapio Olkkola","orcid":"https://orcid.org/0000-0001-7872-8665","observed_orcids":["https://orcid.org/0000-0001-7872-8665"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Klaus T. Olkkola","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089475081","display_name":"Pertti J. Neuvonen","orcid":"https://orcid.org/0000-0003-3631-9411","observed_orcids":["https://orcid.org/0000-0003-3631-9411"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Pertti J. Neuvonen","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I133731052"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":6.3223,"has_fulltext":false,"cited_by_count":114,"citation_normalized_percentile":{"value":0.97815835,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"61","issue":"1","first_page":"8","last_page":"14"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triazolam","display_name":"triazolam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7609999775886536},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.925000011920929},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.7490000128746033},{"id":"https://openalex.org/keywords/psychomotor-effects","display_name":"psychomotor effects","score":0.6299999952316284},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.7620000243186951},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.35499998927116394}],"concepts":[{"id":"https://openalex.org/C2779738154","wikidata":"https://www.wikidata.org/wiki/Q412143","display_name":"Triazolam","level":4,"score":0.9955824613571167},{"id":"https://openalex.org/C2778000748","wikidata":"https://www.wikidata.org/wiki/Q423071","display_name":"Midazolam","level":3,"score":0.7264364361763},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.6964478492736816},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.680625319480896},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6551069617271423},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6331478357315063},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.5731413960456848},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5623764991760254},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4594460725784302},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.42290258407592773},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41420426964759827},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.401502400636673},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.37457913160324097},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2570209801197052},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.21361324191093445},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.12820520997047424},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.10870906710624695},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000904","descriptor_name":"Antibiotics, Antitubercular","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(97)90176-4","doi":"https://doi.org/10.1016/s0009-9236(97)90176-4","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(97)90176-4","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:9024169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9024169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W36420567","https://openalex.org/W57620538","https://openalex.org/W1834946969","https://openalex.org/W1958017720","https://openalex.org/W1975404200","https://openalex.org/W1979855339","https://openalex.org/W1984175249","https://openalex.org/W1984337477","https://openalex.org/W1985419749","https://openalex.org/W1994728875","https://openalex.org/W2004576165","https://openalex.org/W2007366202","https://openalex.org/W2024587809","https://openalex.org/W2072370066","https://openalex.org/W2072897211","https://openalex.org/W2093584791","https://openalex.org/W2101886235","https://openalex.org/W2114089215"],"related_works":["https://openalex.org/W2114089215","https://openalex.org/W2012627536","https://openalex.org/W2015613515","https://openalex.org/W2050109686","https://openalex.org/W2168445796","https://openalex.org/W2022627813","https://openalex.org/W2082034987","https://openalex.org/W3104473832","https://openalex.org/W1550454984","https://openalex.org/W2030021013"],"abstract_inverted_index":{"BACKGROUND:":[0],"Triazolam":[1,205],"is":[2,12,20,206,212,234],"metabolized":[3,243],"predominantly":[4],"by":[5,231,244],"cytochrome":[6],"P450":[7],"3A4":[8],"(CYP3A4).":[9],"Rifampin":[10,145],"(rifampicin)":[11],"a":[13,56],"potent":[14,252],"inducer":[15],"of":[16,29,51,98,125,152,156,199,219,223,254],"CYP3A4":[17,224,245],"and":[18,27,39,49,95,173,229],"it":[19],"known":[21],"to":[22,154,165,181,216,236],"markedly":[23,193],"reduce":[24],"plasma":[25,114,150],"concentrations":[26],"effects":[28,97,195],"drugs":[30],"such":[31],"as":[32],"midazolam.":[33],"The":[34,47,110],"possible":[35],"interaction":[36],"between":[37],"rifampin":[38,72,120,202,209,249],"triazolam":[40,52,86,99,115,153,200,220],"was":[41,87,122],"examined":[42],"in":[43,55,118,127,225],"this":[44],"study.":[45],"METHODS:":[46],"pharmacokinetics":[48],"pharmacodynamics":[50],"were":[53,93,100],"investigated":[54],"randomized,":[57],"double-blind":[58],"crossover":[59],"study":[60],"with":[61,102,248],"two":[62],"phases.":[63],"Ten":[64],"young":[65],"healthy":[66],"volunteers":[67],"took":[68],"either":[69],"600":[70],"mg":[71,85],"once":[73],"daily":[74],"or":[75,250],"placebo":[76,129],"for":[77,106],"5":[78],"days.":[79],"On":[80],"the":[81,96,113,119,128,148,157,174,226],"sixth":[82],"day,":[83],"0.5":[84],"administered":[88],"orally.":[89],"Timed":[90],"blood":[91],"samples":[92],"collected":[94],"measured":[101],"five":[103],"psychomotor":[104,190],"tests":[105,191],"10":[107],"hours.":[108],"RESULTS:":[109],"area":[111],"under":[112],"concentration-time":[116],"curve":[117],"phase":[121,130],"only":[123],"5.1%":[124],"that":[126,240],"(0.74":[131],"+/-":[132,136,140,163,167,179,183],"0.14":[133],"versus":[134],"14.8":[135],"1.0":[137],"ng.hr/ml":[138],"[mean":[139],"SEM;":[141],"p":[142],"<":[143,171,187,197],"0.001]).":[144],"pretreatment":[146],"decreased":[147],"maximum":[149],"concentration":[151],"12.4%":[155],"control":[158],"value":[159],"(i.e.,":[160],"from":[161,177],"2.9":[162],"0.2":[164],"0.36":[166],"0.06":[168],"ng/ml":[169],"[p":[170],"0.001])":[172],"elimination":[175],"half-life":[176],"2.8":[178],"0.1":[180,184],"1.3":[182],"hours":[185],"(p":[186,196],"0.001).":[188],"All":[189],"showed":[192],"reduced":[194],"0.01)":[198],"after":[201,221],"pretreatment.":[203],"CONCLUSIONS:":[204],"ineffective":[207],"during":[208,246],"treatment.":[210],"This":[211],"most":[213],"likely":[214],"due":[215],"increased":[217],"metabolism":[218],"induction":[222],"gut":[227],"wall":[228],"liver":[230],"rifampin.":[232],"It":[233],"advisable":[235],"use":[237],"hypnotic":[238],"agents":[239],"are":[241],"not":[242],"treatment":[247],"other":[251],"inducers":[253],"CYP3A4.":[255]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2138644435","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
